It was a pleasure to meet Simon Oberst (Director of Clinical Development, Cancer Research UK Cambridge Centre; Chair, Organisation of European Cancer Institute [OECI] Accreditation & Designation Programme) at the ECCO 2019 European Cancer Summit in Brussels to discuss the latest exciting updates in quality cancer care and how this is evaluated.
1. Is cancer research, education and patient care sufficiently well-coordinated? Are these activities often too separated, potentially depriving patients of the latest valuable advances or best practice? (0:10)
2. Would the establishment of comprehensive cancer centres (CCCs) ensure improvements and new approaches to manage cancer more effectively? (0:38)
3. Should CCCs attempt to manage all, or focus on specific cancer types? (1:20)
4. Should all patients with cancer have access to a CCC to ensure they receive optimal care throughout their disease course? (1:53)
5. Would economic restrictions limit the establishment and operation of CCCs in many territories and how could these be overcome? (2:52)
Simon Oberst has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]
Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]
Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!